1 tablet cont.: Mercurius solubilis Hahnemanni D10 90 mg; Hepar sulfuris D8, Lachesis mutus D12, Phytolacca americana D4, Ailanthus altissima D3, Echinacea angustifolia D3 30 mg each; Atropa belladonna D4 60 mg.
Furuncles, carbuncles and other suppurations, including, e.g. those in the (peri)-ton- sillar tissue.
Contraindications: Hypersensitivity to one of the active ingredients or excipients, or to plants of the composite family. As a matter of principle, Echinacea should not be used in progressive, systemic diseases such as tuberculosis, leukemia or leukemia-like dis- eases, inflammatory diseases of the connective tissue (collagen disease), autoimmune diseases, multiple sclerosis, AIDS, HIV infections or other chronic viral diseases.
Side effects: Hypersalivation may occur after administration, in which case the use of this product should be discontinued. Hypersensitivity reactions can occur in individual cases. Skin rash and itching (pruritus), and in rare cases facial swelling, shortness of breath (dyspnea), dizziness and a fall in blood pressure, have been observed after treatment with products containing Echinacea extracts. Allergic reactions may occa- sionally occur on account of the homeopathic active substance Mercurius solubilis, too.
Interaction with other medications: None known.
See chapter Dosage of Heel Medications in Veterinary Medicine, p. 17–20.
Packs containing 50 and 250 tablets.